Press release
Biologics Market Research Report 2022-2027: Top Companies (AbbVie Inc., Amgen Inc., AstraZeneca plc)
According to IMARC Group latest report titled "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on biologics market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global biologics market reached a value of US$ 294 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 501.9 Billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027.Biologics, also known as biological medications, represent disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of elements of living organisms. They include several products, such as genes, tissues, allergens, vaccines, blood components, cells, and recombinant proteins, derived from animals, birds, insects, humans, plants, and microorganisms. Biologics modify human hormones and cells and control the production of vital proteins while creating substances to activate and suppress the immune system. They also change the manner of operation of natural intracellular and cellular actions. In addition, biologics are utilized to treat various illnesses and conditions, including ulcerative colitis, Crohn's disease, rheumatoid arthritis, and other autoimmune ailments.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/biologics-market/requestsample
Market Trends:
The escalating cases and diagnosis of chronic diseases have necessitated the availability of advanced diagnostics and treatment drugs, which are among the primary factors driving the biologics market. Besides this, the launch of several policies by the government bodies to promote the healthcare sector and ensure the availability of innovative medicine, owing to the sudden outbreak of the COVID-19 pandemic across the globe, is further augmenting the market growth. Moreover, the introduction of advanced methods of manufacturing biologics genetically to target a specific part of the immune system that fuels inflammation is also catalyzing the global market. Apart from this, scientists and researchers are extensively investigating species and expression techniques to enhance the productivity of biological variants, which are acting as significant growth-inducing factors. Furthermore, the inflating investments of the leading pharmaceutical companies in research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn's disease are expected to bolster the biologics market in the coming years.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/biologics-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi
Biologics Market Segmentation:
Our report has categorized the market based on region, source, product, disease and manufacturing.
Breakup by Source:
• Microbial
• Mammalian
• Others
Breakup by Product:
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others
Breakup by Disease:
• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others
Breakup by Manufacturing:
• Outsourced
• In-House
Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
Browse Other Reports:
Chewing Gum Market: https://www.abnewswire.com/pressreleases/chewing-gum-market-2022-size-us-309-billion-by-2027-growth-cagr-of-3-top-companies-lotte-cloetta-hershey_625898.html
Financial Analytics Market:
https://www.abnewswire.com/pressreleases/financial-analytics-market-share-applications-segments-business-strategies-analysis-and-forecast-20222027_625904.html
Voice and Speech Recognition Market: https://www.abnewswire.com/pressreleases/voice-and-speech-recognition-market-2022-industry-insight-drivers-applications-global-analysis-and-forecast-by-2027_626341.html
Halal Cosmetics Market: https://www.abnewswire.com/pressreleases/halal-cosmetics-market-20222027-current-trends-top-companies-analysis-growth-factors-and-business-opportunities_626343.html
Electronic Warfare Market: https://www.abnewswire.com/pressreleases/electronic-warfare-market-share-top-key-players-latest-trends-industry-status-and-forecast-20222027_625648.html
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics Market Research Report 2022-2027: Top Companies (AbbVie Inc., Amgen Inc., AstraZeneca plc) here
News-ID: 2828294 • Views: …
More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India seafood…

India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025:
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.50 Billion
Market Size in 2033: USD 5.90 Billion
Market Growth Rate (CAGR) 2025-2033: 10.03%
How Big is the India Mutual Funds Industry?
The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033.
Request…

Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview:
The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…

Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay.
IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
More Releases for Biologics
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market
What is the…
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Biologics Contract Manufacturing Market - Strategic biologics manufacturing part …
Newark, New Castle, USA: The "Biologics Contract Manufacturing Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Biologics Contract Manufacturing Market: https://www.growthplusreports.com/report/biologics-contract-manufacturing-market/8606
This latest report researches the industry structure,…